ImageneBio Inc (IMA) has a consensus analyst rating of Buy, based on 5 analysts covering the stock. Of those, 4 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for IMA is $1.33, representing a -76.5% downside from the current price of $5.65. Price targets range from a low of $1.33 to a high of $1.33.
